LIDOCAINE HYDROCHLORIDE AND DEXT
Price to win
From deduped DIBBS award lines (unit cost × quantity). Not a bid recommendation — observed history only.
Average unit cost
$230.88
Weighted average
$216.34
Weighted by quantity
Observed range
$169–$287
Coverage
20 awards
Jul 19, 2017 – Jan 6, 2026
Average: $230.88 · Weighted avg: $216.34 · Range: $169.00–$287.00 · Based on 20 awards, Jul 19, 2017–Jan 6, 2026.
Unit cost by award date · 20 priced lines
DIBBS award history
Distinct award lines for this NSN (deduped). Line total is unit cost × quantity.
20 distinct award lines
| Date | Manufacturer | Qty × unit | Total | Contract |
|---|---|---|---|---|
| Jan 6, 2026 | 94J50PROFESSIONAL INNOVATIVE SOLUTIONSHAYMARKET, VASAM | 15 × $275.00 | $4,125 | SPE2DP26V0301 |
| May 29, 2025 | 0ZSM5NAR MEDICAL DEPOT, LLCGREER, SCSAM | 2 × $283.00 | $566 | SPE2DP25V2309 |
| Aug 16, 2024 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 1 × $287.00 | $287 | SPE2DP24V2295 |
| Feb 20, 2024 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 3 × $275.00 | $825 | SPE2DP24V0872 |
| Jan 26, 2024 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 3 × $269.00 | $807 | SPE2DP24V0633 |
| Jan 22, 2024 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 5 × $265.00 | $1,325 | SPE2DP24V0605 |
| Jul 7, 2023 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 4 × $264.00 | $1,056 | SPE2DP23V1935 |
| May 31, 2023 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 2 × $251.44 | $503 | SPE2DP23V1643 |
| May 24, 2023 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 9 × $248.21 | $2,234 | SPE2DP23V1584 |
| Apr 6, 2023 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 8 × $244.00 | $1,952 | SPE2DP23V1197 |
| Mar 22, 2023 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 18 × $226.00 | $4,068 | SPE2DP23V1054 |
| Mar 6, 2023 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 5 × $232.00 | $1,160 | SPE2DP23V0923 |
| Feb 28, 2023 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 15 × $228.00 | $3,420 | SPE2DP23V0866 |
| Apr 29, 2021 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 2 × $188.00 | $376 | SPE2DP21V0959 |
| Jul 15, 2019 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 2 × $187.00 | $374 | SPE2DP19V0628 |
Manufacturers who have won this NSN
Distinct CAGEs with a confirmed DIBBS award line for this part — each opens the manufacturer page.
Approved manufacturers
Qualified to supply per MCRL — no confirmed DIBBS award on record for this NSN. Each CAGE opens the manufacturer page.
PN NDC00264-9594-10, P5941
PN 95-0915
Characteristics
FLIS item characteristics from PUB LOG identification.
| Characteristic | Value |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT 0.400 AND PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT 5.000 |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJECTION USP 500ML BAG 24S |
| PRIMARY CONTAINER CONTENT QUANTITY | MILLILITERS 500.000 |
| PRIMARY CONTAINER TYPE | BAG, PLASTIC |
| SPECIAL FEATURES | 0.4% LIDOCAINE HCL AND 5% DEXTROSE INJECTION USP. EXCEL CONTAINER IS LATEX FREE, PVC FREE, AND DEHP FREE. APPROVED REPLACEMENT FOR 6505-01-153-4324. |
| TOTAL PRIMARY CONTAINER QUANTITY | 24 |
Open buys
DIBBS · quotes by Sep 16, 2026 · UNRESTRICTED
